ALPHARETTA, Ga., Nov. 16 /PRNewswire/ -- Brookstone Pharmaceuticals, an emerging specialty pharmaceutical company, announced today its decision to change the name of the company to Acella Pharmaceuticals, LLC. This decision has been made to create a company image and brand that more accurately mirrors our commitment to "Accelerating the Health Care Solution" by bringing quality affordable products to customers and patients. Mark Pugh, CEO states, "As we have grown over the last few years, we have evolved into a more integrated pharmaceutical company. We believe this new name, Acella Pharmaceuticals, LLC, better aligns our company's image with our mission of delivering our customers the highest quality product at affordable prices."
If you have any immediate questions, please contact us at 678-325-5188.
CONTACT: Leigh Nickens, +1-678-325-5188
Web site: http://www.AcellaPharma.com/